Medical devices, healthcare technology and the business of care
510(k) clearance · K261225

CAS-One IR

Cascination AG · Decision date Sep 29, 2026

MEDTECHLEDGER EXPLANATIONK261225

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision for CAS-One IR, submitted by Cascination AG of Bern, Switzerland, under 510(k) number K261225. The public database lists the decision date as September 29, 2026, with the application received April 15, 2026, while the clearance letter in the summary document is dated August 28, 2026; the record does not reconcile those dates. The device is classified as a computed tomography x-ray system under 21 CFR 892.1750, Class II, product code JAK, in the radiology specialty. SESE denotes 510(k) clearance, not premarket approval.

The subject device comprises CAS-One IR Software as the parent device plus eight accessories, including a platform, baseplate, cushion, accessory tray, aiming device, guide arm, pointer and consumable set. The summary describes it as an updated version of predicate K232022, with intended use, functionality, use context and workflow stated as unchanged. The summary states the accessories perform no standalone medical function independent of the software. The record does not include performance testing data or a detailed comparison of changes from the predicate.

The indications describe a user-controlled stereotactic accessory for planning, navigation and verification during CT-guided percutaneous procedures with rigid straight instruments, for patients older than 18 years. Those indications are attributed to the September 2026 summary and should not be read as current labeling beyond this record.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Radiology
Decision date
Sep 29, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K261225
Regulatory pathway
510(k) premarket notification
Product code
JAK
Decision code
SESE
Decision date
Sep 29, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: System, X-Ray, Tomography, Computed.

Product code
JAK
FDA device class
2

FDA decision timeline

  1. K261225 received

    Application receipt date recorded by FDA.

  2. K261225 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code JAK

Product / regulatory recordCompanyPathwayDecision dateSource
Coreline Soft Co., Ltd.510(k) clearanceOct 16, 2026FDA
Samsung HME America, Inc., dba NeuroLogica Corp.510(k) clearanceSep 22, 2026FDA
Fujifilm Corporation510(k) clearanceSep 18, 2026FDA
Fujifilm Corporation510(k) clearanceSep 4, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Cascination AG

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Bern

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records